[Endoscopic versus endoscopic plus octreotide treatment for acute variceal bleeding. Benefit according to severity at admission].

Unlabelled: Vasoactive agents plus endoscopic treatment was recommended in esophageal variceal bleeding (EVB). However, the use according to severity on admission has been poorly evaluated

Objectives: To evaluate the efficacy of endoscopic versus endoscopic plus octreotide treatment in patients with EVB according to severity on admission.

Methods: Between June 2001 and December 2011, 247 patients with EVB were treated using endoscopic or combined endoscopic plus octreotide treatment.

[Generalized secondary peritonitis: predictors of in-hospital mortality and survival and mortality evolutive links].

Background: The knowledge of mortality predictors and evolutive variables linked with in-hospital death can help us to optimize corrective procedures.

Objectives: To identify independent predictors of in-hospital mortality and survival, and independent evolutive links with death in patients with generalized secondary peritonitis (GSP).

Methods: Two hundred and forty-two patients admitted into the hospital due to GSP were followed until in-hospital death or hospital discharge.

[Mediastinis related to esophagogastric disease and injury. Warning clinical signs and independent predictors of intrahospitalary survival].

Objective: To identify clinical warning signs and independent predictors of survival in mediastinitis related to esophagogastric diseases and injuries.

Methods: From March 1998 to February 2009, 36 patients with a mean age of 55.7 +/- 12.

[Predictors of intrahospitalary mortality in the upper gastrointestinal variceal bleeding due to chronic liver disease treated endoscopically].

Unlabelled: Upper gastrointestinal variceal bleeding is one of the most serious complications in patients with chronic liver disease. The aim of this trial is to identify in hospital mortality predictors in this illness.

Material And Methods: 106 hospitalizations due to this disease from October 2001 to April 2006 in cohort design.